Myocarditis is a major cause of sudden death in people under 40 years of age. While some myocarditis patients recover, many of them progress to dilated cardiomyopathy, an often fatal condition and a frequent reason for cardiac transplantation. Many cases of myocarditis are associated with an autoimmune process in which cardiac myosin is a major autoantigen. The mechanisms leading to the immune-mediated damage to the heart, particularly the role of cytokines, are not fully elucidated. We propose to study these mechanisms using the murine model of cardiac myosin-induced experimental autoimmune myocarditis (EAM) previously established in our laboratory. The goal of the present proposal is to delineate the mechanisms by which IL-4 and IFN-gamma, prototypic Th2 and Th1 cytokines respectively, influence the disease process. Our interest in these two cytokines is based on our preliminary findings which indicate that IL-4 has a disease-promoting role in EAM, whereas IFN-gamma limits the disease.
Specific aims 1 and 2 will address the role of IL-4 in EAM and the mechanisms by which IL-4 promotes disease.
Specific aims 3 and 4 will examine the role of IFN-gamma and the mechanisms by which IFN-gamma limits disease. We are planning to achieve these specific aims by blocking cytokines with specific antibodies, using cytokine and cytokine receptor knock out mice, and transferring disease with antibodies and subsets of T cells. Disease outcomes will be assessed by gross and histologic examination of the hearts. In vivo assessment will include echocardiography and pressure-volume analysis. Our preliminary findings contrast with the prevailing opinion that organ-specific autoimmune diseases are driven by a Th1 response and are ameliorated by a Th2 response. The proposed study will help us understand how Th1 responses may limit and Th2 responses may promote organ-specific autoimmunity. It will also provide us with a basis for designing new therapeutic interventions in patients with myocarditis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL067290-02
Application #
6621816
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Massicot-Fisher, Judith
Project Start
2001-12-01
Project End
2005-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
2
Fiscal Year
2003
Total Cost
$286,125
Indirect Cost
Name
Johns Hopkins University
Department
Pathology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Rose, Noel R (2016) Viral myocarditis. Curr Opin Rheumatol 28:383-9
Rose, Noel R (2015) Molecular mimicry and clonal deletion: A fresh look. J Theor Biol 375:71-6
Rose, Noel R (2014) Learning from myocarditis: mimicry, chaos and black holes. F1000Prime Rep 6:25
Barin, Jobert G; Baldeviano, G Christian; Talor, Monica V et al. (2013) Fatal eosinophilic myocarditis develops in the absence of IFN-? and IL-17A. J Immunol 191:4038-47
Barin, Jobert G; Baldeviano, G Christian; Talor, Monica V et al. (2012) Macrophages participate in IL-17-mediated inflammation. Eur J Immunol 42:726-36
Barin, Jobert G; Rose, Noel R; Ciháková, Daniela (2012) Macrophage diversity in cardiac inflammation: a review. Immunobiology 217:468-75
Chen, P; Baldeviano, G C; Ligons, D L et al. (2012) Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4(+) T cells. Clin Exp Immunol 169:79-88
Rose, Noel R (2011) Critical cytokine pathways to cardiac inflammation. J Interferon Cytokine Res 31:705-10
Hedayat, Mona; Mahmoudi, Mohammad Jafar; Rose, Noel R et al. (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15:543-62
Barin, Jobert G; Talor, Monica V; Baldeviano, G Christian et al. (2010) Mechanisms of IFN? regulation of autoimmune myocarditis. Exp Mol Pathol 89:83-91

Showing the most recent 10 out of 48 publications